Stay updated on MGCD516 Study in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.

Latest updates to the MGCD516 Study in Advanced Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on various cancers and related studies. Notably, the page now includes references to sitravatinib and its clinical studies, enhancing the content's relevance to cancer treatment.SummaryDifference14%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check37 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to MGCD516 Study in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGCD516 Study in Advanced Cancer Clinical Trial page.